向BST2的SPARCL1通过激活NF-κB/P65通路来调解阴茎炎症和代谢功能障碍
Chunyu Wu1,2,3,4, Liangliang Liu1,2,3,4, Yongzhi Lin1,2,3,4
1Department of Joint Surgery, Center for Orthopedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Rheumatology (Oxford, England)
|July 10, 2025
概括
通过激活NF-κB/P65通路,SPARCL1蛋白会加剧阴囊变性. 在体内和体外抑制SPARCL1减少了炎症和代谢,为阴茎损伤提供了潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 整形外科 整形外科 整形外科
背景情况:
- 阴茎损伤是一种常见的肌肉骨疾病.
- 精确的驱动阴茎退行症的机制尚未完全理解.
- 确定关键的分子参与者对于开发向疗法至关重要.
研究的目的:
- 为了研究SPARCL1 (SPARCL1) 在半月膜退化病变发生过程中的作用.
- 阐明SPARCL1影响阴茎健康的分子机制.
主要方法:
- 来自人类骨关节炎和非骨关节炎阴道样本的转录组测序数据的分析.
- 在小鼠模型 (ACLT) 和人类变性阴茎中验证SPARCL1表达.
- 在体内用lentiviruses和体内过度表达研究对SPARCL1进行 Knockdown.
- 检测细胞外矩阵组件,代谢指标和NF-κB/P65通路.
- 使用分子生物学技术研究SPARCL1和BST2之间的相互作用.
主要成果:
- 在退化的阴茎组织中,SPARCL1的表达显著上调.
- 抑制SPARCL1减弱了炎症和细胞代谢,在体内延迟了退化.
- 过度表达SPARCL1促进了阴囊细胞中的炎症和代谢代谢.
- BST2被确定为SPARCL1的下游目标,它们的相互作用激活NF-κB/P65通路.
结论:
- 通过SPARCL1与BST2结合,可以激活NF-κB/P65信号通路.
- 这种激活导致阴囊炎炎症增加,并增强了代谢代谢.
- SPARCL1在恶化阴囊退化方面发挥着关键作用,呈现出潜在的治疗标.
相关概念视频
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K


